Showing results (41-50 of 118) with videos related to
Sort By:
Pageof 12
Journal of Clinical Medicine|August 27, 2021
Etiological Work-Up for Adults with Bronchiectasis: A Predictive Diagnostic Score for Primary Ciliary Dyskinesia and Cystic FibrosisFrederic Schlemmer, Agnes Hamzaoui, Sonia Zebachi, et al.Targeted Oncology|August 2, 2017
Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study)Jean-Bernard Auliac, Isabelle Monnet, Catherine Dubos-Arvis, et al.Cancer Medicine|November 21, 2019
Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04)Alain Vergnenegre, Margaux Geier, Florian Guisier, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 7, 2012
Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trialMichaël Duruisseaux, Laurence Baudrin, Elisabeth Quoix, et al.Cancers|October 23, 2021
EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and ChemotherapySamy Chelabi, Xavier Mignard, Karen Leroy, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2010
Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 studyRenaud Descourt, Alain Vergnenegre, Fabrice Barlesi, et al.Thrombosis and Haemostasis|April 20, 2021
Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort StudyPhilippe Girard, Silvy Laporte, Céline Chapelle, et al.Lung Cancer (Amsterdam, Netherlands)|March 3, 2023
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo)Alain Vergnenegre, Isabelle Monnet, Charles Ricordel, et al.Journal of Thoracic Disease|December 23, 2017
Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC GroupHervé Le Caer, Isabelle Borget, Romain Corre, et al.Lung Cancer (Amsterdam, Netherlands)|March 9, 2025
Evaluation of teleguided high-intensity exercise rehabilitation at home before lung-cancer surgery (PREPACHIR Study)Florent Vinas, Hélène Goussault, Laurent Boyer, et al.Pageof 12